Ofatumumab Increases NEDA-3 Likelihood in MS Compared With Teriflunomide
May 26th 2020Novartis’s anti-CD20 monoclonal antibody has been shown to increase the odds of patients with multiple sclerosis achieving no evidence of disease activity status by more than 3-fold in the first year and more than 8-fold in the second year.
NIH Data Suggest Brain Glucose Metabolism Is Linked to Alzheimer Pathogenesis
May 22nd 2020The data included more than 2000 brains and approximately 400 cerebrospinal fluid samples, and showed that a protein network module linked to glucose metabolism was also elevated in cerebrospinal fluid in early stages of the disease.